implicationforpotencytestingandimmuneprocessing. JVirol.https://doi.org
72. An, Y. et al. N-glycosylation of seasonal influenza vaccine hemagglutinins
glycansinviralevolutionandvaccinedesign. Sci.Transl.Med. 2,24ra21(2010).
71. Wei,C.J.etal.Cross-neutralizationof1918and2009influenzaviruses:roleo
influenzavaccine:evidencefromamousemodel. J.Med.Virol. 72,138–142(2004)
70. Babiuk,S.etal.AggregatecontentinfluencestheTh1/Th2immuneresponset
(2002).
passive surveillance, Canada 2001-2002. Can. Commun. Dis. Rep. 28, 189–19
69. Choudhri,Y.&Walop,W.Influenzavaccine-associatedadverseevents:resultso
sonsinCanada. Can.Commun.Dis.Rep. 31,217–225(2005).
vaccination:reviewofpost-marketing surveillance throughfourinfluenza sea
68. PublicHealthAgencyofCanada.Oculo-respiratorysyndromefollowinginfluenz
10.3390/vaccines6020031(2018).
virus and within vaccines using electron microscopy. Vaccines https://doi.org
67. Gallagher, J. R. et al. Characterization of hemagglutinin antigens on influenz
tionofinfluenzavirusvaccine. Hum.VaccinesImmunother. 11,1673–1684(2015).
66. Tay,T.etal.Investigationintoalternativetestingmethodologiesforcharacteriza
dependentantibodyresponsesinhumans. NPJVaccines 5,77(2020).
unit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell
65. Richards,K.A.etal.RecombinantHA-basedvaccineoutperformssplitandsub
8,99(2020).
neutralizingantibodiesagainststructurallydistinctdomainsofH3N2HA. Vaccine
64. Portnoff,A.D.etal.Influenzahemagglutininnanoparticlevaccineelicitsbroadl
hemagglutininfusionmachineryoninfluenzavirions. Sci.Adv. 6,eaaz8822(2020)
63. Benhaim, M. A. etal. Structural monitoring of a transient intermediate in th
allinfluenzaAsubtypes. Cell 166,596–608(2016).
62. Kallewaard,N.L.etal.Structureandfunctionanalysisofanantibodyrecognizin
epitope. Science 324,246–251(2009).
61. Ekiert, D. C. et al. Antibody recognition of a highly conserved influenza viru
differentinfluenzavaccineplatformsinhumans. Nat.Commun. 10,3338(2019)
60. Khurana,S.etal.Repeatvaccinationreducesantibodyaffinitymaturationacros
e3000139(2019).
separation of hemagglutinin receptor-binding head domains. PLoS Biol. 17
59. Turner,H.L.etal.Potentanti-influenzaH7humanmonoclonalantibodyinduce
(2015).
broadly cross-reactive antibodies. Curr. Top. Microbiol. Immunol. 386, 323–34
58. Lee,P.S.&Wilson,I.A.Structuralcharacterizationofviralepitopesrecognizedb
(1983).
hemagglutininmoleculeofH3influenzavirusatacidicpH. Virology 126,587–59
57. Webster,R.G.,Brown,L.E.&Jackson,D.C.Changesintheantigenicityofth
insectandmammaliancells. Curr.Opin.Biotechnol. 10,428–433(1999).
56. Kost,T.A.&Condreay,J.P.Recombinantbaculovirusesasexpressionvectorsfo
revealsstructuralpolymorphisms. Clin.Vaccin.Immunol. 23,483–495(2016).
hemagglutinin complexes by cryo-electron microscopy and image analyse
55. McCraw,D.M.,Gallagher,J.R.&Harris,A.K.Characterizationofinfluenzavaccin